Empress is a startup based in the United States.
Empress Therapeutics integrates automated functional genomics, chemoproteomics, and multi-omics with causal machine learning to provide drug discovery teams with mechanistic insights for target deconvolution and molecule prioritization.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.